Detailed dissection of a new mechanism for glycoside cleavage: alpha-1,4-glucan lyase.
The unusual enzyme, Gracilariopsis alpha-1,4-glucan lyase of the sequence-related glycoside hydrolase family 31, cleaves the glycosidic bond of alpha-1,4-glucans via a beta-elimination reaction involving a covalent glycosyl-enzyme intermediate (Lee, S. S., Yu, S., and Withers, S. G. (2002) J. Am. Chem. Soc. 124, 4948-4949). The classical bell-shaped pH dependence of k(cat)/K(m) indicates two ionizable groups in the active site with apparent pK(a) values of 3.05 and 6.66. Brønsted relationships of log k(cat) versus pK(a) and log(k(cat)/K(m)) versus pK(a) for a series of aryl glucosides both show a linear monotonic dependence on leaving group pK(a) with low beta(lg) values of 0.32 and 0.33, respectively. The combination of these low beta(lg) values with large secondary deuterium kinetic isotope effects (k(H)/k(D) = 1.16 - 1.19) on the first step indicate a glycosylation step with substantial glycosidic bond cleavage and proton donation to the leaving group oxygen at the transition state. Developed oxocarbenium ion character of the transition state is also suggested by the potent inhibition afforded by acarbose and 1-deoxynojirimycin (K(i) = 20 and 130 nM, respectively) and by the substantial rate reduction afforded by adjacent fluorine substitution. For only one substrate, 5-fluoro-alpha-D-glucopyranosyl fluoride, was the second elimination step shown to be rate-limiting. The large alpha-secondary deuterium kinetic isotope effect (k(H)/k(D) = 1.23) at C-1 and the small primary deuterium kinetic isotope effect (k(H)/k(D) = 1.92) at C-2 confirm an E2 mechanism with strong E1 character for this second step. This considerable structural and mechanistic similarity with retaining alpha-glucosidases is clear evidence for the evolution of an enzyme mechanism within the family.
Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z1.
Seung Seo
SS
Lee
Shukun
S
Yu
Stephen G
SG
Withers
D017485:1-Deoxynojirimycin / Q000737:chemistry; D020909:Acarbose / Q000737:chemistry; D000818:Animals; D002384:Catalysis; D003903:Deuterium / Q000737:chemistry; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000737:chemistry; D005936:Glucans / Q000737:chemistry*; D005942:Gluconates / Q000737:chemistry; D005947:Glucose / Q000031:analogs & derivatives* / Q000737:chemistry; D006027:Glycosides / Q000737:chemistry*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007097:Imines / Q000737:chemistry; D007700:Kinetics; D051379:Mice; D011133:Polysaccharide-Lyases / Q000037:antagonists & inhibitors / Q000737:chemistry*; D013379:Substrate Specificity
C439387:5-fluoroglucopyranosyl fluoride; D004791:Enzyme Inhibitors; D005936:Glucans; D005942:Gluconates; D006027:Glycosides; D007097:Imines; C067867:gluconohydroximo-1,5-lactone; D017485:1-Deoxynojirimycin; C040088:1,4-glucan; D003903:Deuterium; D011133:Polysaccharide-Lyases; C080474:alpha-1,4-glucan lyase; D005947:Glucose; D020909:Acarbose